STOCK TITAN

Henry Schein, Inc. 8-K Filings

HSIC NASDAQ

Every 8-K that Henry Schein, Inc. (HSIC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow HSIC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSIC filings page.

Rhea-AI Summary

Henry Schein, Inc. reported higher second-quarter 2026 results, with net sales of $3.458 billion, up 6.7% from the prior-year quarter, driven by 4.6% internal sales growth, contributions from acquisitions, and foreign currency tailwinds. Global Distribution and Value-Added Services sales grew 6.6%, Global Specialty Products 8.7%, and Global Technology 8.2%.

GAAP net income attributable to Henry Schein was $94 million, or $0.82 diluted EPS, versus $86 million and $0.70 a year ago. Non-GAAP net income was $145 million, or $1.27 diluted EPS, compared with $135 million and $1.10. Adjusted EBITDA reached $288 million, up from $256 million. For the first half of 2026, net sales were $6.826 billion, up 6.5%. The company raised 2026 guidance to non-GAAP diluted EPS of $5.29–$5.39, total sales growth of 4.5%–5.5%, and mid to high-single-digit Adjusted EBITDA growth, and repurchased 2.6 million shares in the quarter for $200 million.

Rhea-AI Summary

Henry Schein, Inc. announced a leadership restructuring, creating a Henry Schein Leadership Team to replace its Executive Management Committee and integrating its global supply chain with its global distribution group. The company states these changes are intended to sharpen strategic priorities, accelerate execution, and enhance collaboration.

Effective October 30, 2026, Executive Vice Presidents Michael S. Ettinger and Mark E. Mlotek and Senior Vice President James Mullins will leave their current roles and continue as Senior Advisors, with Ettinger and Mlotek entitled to payments and benefits under the Executive Severance Plan. Henry Schein reported $13.2 billion in 2025 sales and an approximately 11.0 percent compound annual growth rate since its 1995 IPO.

Rhea-AI Summary

Henry Schein, Inc. reported results of its 2026 Annual Meeting of Stockholders and a leadership change on its Board. Stockholders elected ten incumbent directors for terms expiring in 2027, approved on an advisory basis the 2025 compensation of Named Executive Officers, and ratified BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 26, 2026. A shareholder proposal to Govern by Majority Vote received substantial support but did not pass, with 59,487,608 votes for, 43,707,406 against, 154,122 abstentions and 5,933,309 broker non-votes. The Board elected William K. “Dan” Daniel as Independent Chairman effective May 21, 2026, succeeding long-time director Stanley M. Bergman, who retired from the Board after 44 years and was named Chairman Emeritus. The company notes that its sales reached $13.2 billion in 2025 and have grown at a compound annual rate of approximately 11.0 percent since becoming a public company in 1995.

Rhea-AI Summary

Henry Schein, Inc. reported solid first-quarter 2026 results, with net sales of $3.37 billion, up 6.3% from the prior year. GAAP diluted EPS rose to $0.92 from $0.88, while non-GAAP diluted EPS increased to $1.32 from $1.15, a 14.8% gain.

Adjusted EBITDA grew to $289 million from $259 million, reflecting improved profitability. The company repurchased 1.6 million shares for $125 million and reaffirmed its 2026 outlook, including non-GAAP EPS of $5.23–$5.37, total sales growth of 3%–5%, and mid-single-digit Adjusted EBITDA growth.

Rhea-AI Summary

Henry Schein reported solid growth for the fourth quarter and full year 2025 and introduced 2026 guidance. Q4 2025 net sales were $3.44 billion, up 7.7% year over year, with GAAP diluted EPS of $0.85 versus $0.74 and non-GAAP diluted EPS of $1.34 versus $1.19. Growth was broad-based, including double-digit gains in dental equipment, specialty products and technology. For 2025, net sales reached $13.18 billion, up 4.0%, with GAAP diluted EPS of $3.27 and non-GAAP diluted EPS of $4.97. The company repurchased 12.1 million shares for $850 million in 2025 and ended the year with $780 million remaining under its authorization. For 2026, Henry Schein expects non-GAAP diluted EPS of $5.23 to $5.37, total sales growth of about 3% to 5%, and mid-single-digit Adjusted EBITDA growth, reflecting continued execution of its BOLD+1 strategic plan.

Rhea-AI Summary

Henry Schein, Inc. appointed Frederick Lowery as its new Chief Executive Officer, effective March 2, 2026, and expanded the Board from 14 to 15 members to add him as a director. Longtime CEO Stanley M. Bergman will remain in place until Mr. Lowery starts and will then continue as Chairman of the Board.

Under his employment agreement, Mr. Lowery will receive a base salary of $1,250,000 and a target annual bonus opportunity of at least 150% of base salary, with 2026 bonus metrics based 70% on earnings per share and 30% on a strategic scorecard. For fiscal 2026, his annual bonus payout will be at least $1,875,000, and he is slated to receive 2026 equity awards with a target grant-date value of $10,000,000 split among stock options, time-based restricted stock units, and performance-based restricted stock units.

He will also receive a one-time cash bonus of $1,184,000 and a special sign-on equity award of $2,500,000 in restricted stock units, plus up to $500,000 in reimbursed relocation expenses. The company amended and restated its Executive Severance Plan so that the Chief Executive Officer is eligible for severance and change-in-control protections, and adopted Fifth Amended and Restated By-Laws, both of which are filed as exhibits.

Rhea-AI Summary

Henry Schein, Inc. (HSIC) furnished an update on its business by issuing a press release with financial results for the three and nine months ended September 27, 2025. The press release is attached as Exhibit 99.1 and was provided under Item 2.02.

The information described is furnished to the SEC and is not deemed filed under the Securities Exchange Act of 1934.

Rhea-AI Summary

Henry Schein, Inc. reported a leadership change involving longtime executive James Breslawski. As previously disclosed, he moved from President to Senior Advisor and member of the Executive Management Committee on April 1, 2025. On September 5, 2025, he transitioned out of this Senior Advisor role and is no longer serving in that position. The company states that, in connection with this transition, Mr. Breslawski will receive payments and benefits provided under Henry Schein’s Executive Severance Plan, which governs how senior executives are compensated when they leave qualifying roles.